
|Videos|March 5, 2021
Dr. Bishoy M. Faltas on the role of genomic testing in bladder cancer
Author(s)Urology Times staff
“The role of genomic testing in bladder is expanding almost every year,” says Faltas.
Advertisement
Bishoy M. Faltas, MD, assistant professor of Medicine at Weill Cornell Medicine, explains the growing role of genomic testing in bladder cancer, including the emerging understanding of the role of germline alterations.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Lymph Node Dissection Following Systemic Therapy in MIBC
2
Mina Fam, MD, highlights significance of tebipenem pivoxil approval for cUTI
3
Unmet needs and emerging solutions in MRI-guided prostate cancer care
4
Enzalutamide plus talazoparib demonstrates clinical activity in mHSPC
5












